Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kaye

Showing results (111-120 of 418) with videos related to

Pageof 42
Sort By:
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|August 28, 2018
Subclinical Left Ventricular Dysfunction is Influenced by Genotype Severity in Patients with Cystic FibrosisMichael Pallin, Dominic Keating, David M Kaye, et al.
Pharmacogenetics|July 2, 2003
Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failureDavid M Kaye, Belinda Smirk, Carolyn Williams, et al.
Journal of Cellular Biochemistry|June 23, 2009
Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injuryKylie M Venardos, Amanda J Zatta, Tanneale Marshall, et al.
Heart, Lung & Circulation|February 14, 2022
Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical ChallengesFiona Thoi, Daniel J Scherer, David M Kaye, et al.
The American Journal of Cardiology|August 3, 2023
A Digital Application to Assist With Device Selection in Patients Who Undergo Transcatheter Aortic Valve ImplantationAndrew Kawai, Samer Noaman, Dion Stub, et al.
British Journal of Clinical Pharmacology|February 13, 2003
Low-dose atorvastatin therapy does not augment endothelial function in active hypercholesterolaemic malesMelinda M Parnell, Jaye P F Chin-Dusting, Jennifer Starr, et al.
Frontiers in Pharmacology|March 7, 2019
CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated CardiomyopathyPo-Yin Chu, Mandar S Joshi, Duncan Horlock, et al.
Frontiers in Bioengineering and Biotechnology|November 27, 2024
Computational modelling of valvular heart disease: haemodynamic insights and clinical implicationsMichael Šeman, Andrew F Stephens, David M Kaye, et al.
International Journal of Molecular Sciences|February 26, 2025
A Genetic Test to Identify People at High Risk of Heart FailureXintian Ge, Bek Brittain, Luke Dawson, et al.
Heart, Lung & Circulation|December 11, 2012
Impact of N-acetylcysteine on endothelial function, B-type natriuretic peptide and renal function in patients with the cardiorenal syndrome: a pilot cross over randomised controlled trialAnthony C Camuglia, Micha T Maeder, Jennifer Starr, et al.
Pageof 42

Showing results (111-120 of 418) with videos related to

Sort By:
Pageof 42
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|August 28, 2018
Subclinical Left Ventricular Dysfunction is Influenced by Genotype Severity in Patients with Cystic FibrosisMichael Pallin, Dominic Keating, David M Kaye, et al.
Pharmacogenetics|July 2, 2003
Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failureDavid M Kaye, Belinda Smirk, Carolyn Williams, et al.
Journal of Cellular Biochemistry|June 23, 2009
Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injuryKylie M Venardos, Amanda J Zatta, Tanneale Marshall, et al.
Heart, Lung & Circulation|February 14, 2022
Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical ChallengesFiona Thoi, Daniel J Scherer, David M Kaye, et al.
The American Journal of Cardiology|August 3, 2023
A Digital Application to Assist With Device Selection in Patients Who Undergo Transcatheter Aortic Valve ImplantationAndrew Kawai, Samer Noaman, Dion Stub, et al.
British Journal of Clinical Pharmacology|February 13, 2003
Low-dose atorvastatin therapy does not augment endothelial function in active hypercholesterolaemic malesMelinda M Parnell, Jaye P F Chin-Dusting, Jennifer Starr, et al.
Frontiers in Pharmacology|March 7, 2019
CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated CardiomyopathyPo-Yin Chu, Mandar S Joshi, Duncan Horlock, et al.
Frontiers in Bioengineering and Biotechnology|November 27, 2024
Computational modelling of valvular heart disease: haemodynamic insights and clinical implicationsMichael Šeman, Andrew F Stephens, David M Kaye, et al.
International Journal of Molecular Sciences|February 26, 2025
A Genetic Test to Identify People at High Risk of Heart FailureXintian Ge, Bek Brittain, Luke Dawson, et al.
Heart, Lung & Circulation|December 11, 2012
Impact of N-acetylcysteine on endothelial function, B-type natriuretic peptide and renal function in patients with the cardiorenal syndrome: a pilot cross over randomised controlled trialAnthony C Camuglia, Micha T Maeder, Jennifer Starr, et al.
Pageof 42